Ocular Therapeutix, Inc SEC filings OCUL
Ocular Therapeutix, Inc has 865 filings in SEC EDGAR's recent list, going back to Mar 6, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 16, 2023 | — |
| CORRESP | Letter to the SEC | Nov 14, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2023 | — |
| EFFECT | Filing | May 10, 2022 | — |
| POSASR | Filing | Feb 28, 2022 | — |
| SEC STAFF LETTER | Filing | Mar 11, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 10, 2021 | — |
| CT ORDER | Filing | Oct 24, 2019 | — |
| EFFECT | Filing | Apr 29, 2019 | — |
| CORRESP | Letter to the SEC | Apr 25, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2019 | — |
| D | Filing | Mar 18, 2019 | — |
| EFFECT | Filing | Feb 12, 2019 | — |
| CORRESP | Letter to the SEC | Feb 8, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2019 | — |
| DEL AM | Filing | Jan 16, 2019 | — |
| CT ORDER | Filing | Oct 19, 2018 | — |
| CT ORDER | Filing | Nov 18, 2016 | — |
| CT ORDER | Filing | Aug 30, 2016 | — |
| EFFECT | Filing | Apr 28, 2016 | — |
| CORRESP | Letter to the SEC | Apr 26, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2016 | — |
| EFFECT | Filing | Jun 4, 2015 | — |
| CORRESP | Letter to the SEC | Jun 2, 2015 | — |
| CORRESP | Letter to the SEC | Jun 2, 2015 | — |
| UPLOAD | Letter from the SEC | May 28, 2015 | — |
| CT ORDER | Filing | Aug 1, 2014 | — |
| EFFECT | Filing | Jul 24, 2014 | — |
| CERTNAS | Auto-generated paper document | Jul 22, 2014 | — |
| CORRESP | Letter to the SEC | Jul 22, 2014 | — |
| CORRESP | Letter to the SEC | Jul 22, 2014 | — |
| 8-A12B | Filing | Jul 21, 2014 | — |
| CORRESP | Letter to the SEC | Jun 27, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2014 | — |
| DRS/A | Filing | Jun 3, 2014 | — |
| UPLOAD | Letter from the SEC | May 23, 2014 | — |
| DRS | Filing | Apr 29, 2014 | — |
| D | Filing | Jun 10, 2013 | — |
| D | Filing | Feb 8, 2011 | — |
| D/A | Filing | Jan 12, 2011 | — |
| D | Filing | Jul 2, 2009 | — |
| D | Filing | Jul 1, 2009 | — |
| D/A | Filing | Jul 1, 2009 | — |
| REGDEX | Auto-generated paper document | Mar 6, 2007 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCUL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedford, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1393434
- Former names
- I-THERAPEUTIX INC (until Jul 2, 2009)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.